At a global level, during the acute phase of the pandemic, health care delivery decreased by 37%.1 This means that numerous services and interactions had to be significantly reduced, including doctor visits (42%), hospitalisations (28%), diagnostic (31%) and therapeutic services (30%).1 On one side, limitations to treatment access have created a backlog that systems must now address; on the other side, some individuals are refraining from seeking care due to fear of infections, or just poor health-related behaviour. In fact, the pandemic exposed and exacerbated existing health inequalities and related disparities in people’s ability to take care of their own health.
Now, as we recover and attempt to mitigate the consequences of the pandemic, there’s an unprecedented opportunity to reshape health systems to deliver value-driven, digitally-enabled services that will help achieve better health and wellbeing for the entire population. To grasp that opportunity, decision-makers will have to prioritise actions and investments in key fields.
The question is now, what did we learn from the pandemic, and how can decision-makers apply those lessons to 'build back better'?
Those are the questions that the report “Health Systems after COVID-19”2 from PwC and the European Federation of Pharmaceutical Industries and Associations (EFPIA) seeks to answer. Above all, the report recognises that the pandemic has created multiple challenges that have had an adverse impact across all components of healthcare systems, from service delivery, to technology and innovation, and financing.
European decision-makers are called to steer the response to COVID-19 shock. To do that, they need to define strategic priorities.
The challenges faced during the pandemic can neither be viewed separately nor tackled individually. They are interlinked by nature, and attempts to address one of them will affect other components of healthcare systems. Therefore, the response to the crisis needs to take place at the health system level, with key decision-makers and stakeholders converging to address the four systemic trends the report identifies:
To find out more, download the study “Health Systems after COVID-19”:
1 Moynihan et al. 2021
2 Health Systems after COVID-19” was carried out jointly by PwC Switzerland and the European Federation of Pharmaceutical Industry Associations (EFPIA). Based on research and consultation with public health experts, EFPIA and industry representatives, patient organizations and PwC leaders, the study provides a vision of how health systems could transform to meet current and future demand for health services.
https://pages.pwc.ch/core-asset-page?asset_id=7014L0000002rOnQAI&embed=true&lang=en
Managing Partner, Advisory and Consulting Leader, PwC Switzerland
Tel: +41 58 792 53 09